The American Journal of Gastroenterology · 2014 · 42 citations · 36 references
AgricultureEndocrinologyNutritionClinical NutritionHuman NutritionNutritional PhysiologyDigestive PhysiologyFunctional Gastrointestinal DisordersGastrointestinal FunctionGastrointestinal PathophysiologyGastrointestinal PhysiologyNutrition In Gastrointestinal DisordersDextrose SolutionsFeeding During Gastrointestinal IllnessGastrointestinal Disorder Nutrition TherapyGastrointestinal Function MonitoringGlucagon-like Peptide 1 SignalingGlucagon-like PeptidesGlucose-dependent Insulin SecretionImpaired Glucose Tolerance
OBJECTIVES: Functional dyspepsia is predominantly attributed to gastric sensorimotor dysfunctions. The contribution of intestinal chemosensitivity to symptoms is not understood. We evaluated symptoms and plasma hormones during enteral nutrient infusion and the association with impaired glucose tolerance and quality-of-life (QOL) scores in patients with functional dyspepsia vs. healthy controls. METHODS: Enteral hormonal responses and symptoms were measured during isocaloric and isovolumic dextrose and lipid infusions into the duodenum in 30 patients with functional dyspepsia (n=27) or nausea and vomiting (n=3) and 35 healthy controls. Infusions were administered in randomized order over 120 min each, with a 120-min washout. Cholecystokinin, glucose-dependent insulinotropic peptide, glucagon-like peptide 1 (GLP1), and peptide YY were measured during infusions. RESULTS: Moderate or more severe symptoms during lipid (4 controls vs. 14 patients) and dextrose (1 control vs. 12 patients) infusions were more prevalent in patients than controls (P≤0.01), associated with higher dyspepsia symptom score (P=0.01), worse QOL (P=0.01), and greater plasma hormone concentrations (e.g., GLP1 during lipid infusion). Moderate or more severe symptoms during enteral infusion explained 18%, and depression score explained 21%, of interpatient variation in QOL. Eight patients had impaired glucose tolerance, associated with greater plasma GLP1 and peptide YY concentrations during dextrose and lipid infusions, respectively. CONCLUSIONS: Increased sensitivity to enteral dextrose and lipid infusions was associated with greater plasma enteral hormone concentrations, more severe daily symptoms, and worse QOL in functional dyspepsia. These observations are consistent with the hypothesis that enteral hormones mediate increased intestinal sensitivity to nutrients in functional dyspepsia.
36
The Hospital Anxiety and Depression Scale
A. S. Zigmond, R. P. Snaith · Acta Psychiatrica Scandinavica · 1983 · 46.6K citations
Impaired duodenal mucosal integrity and low-grade inflammation in functional dyspepsia
Hanne Vanheel, María Vicario, Tim Vanuytsel et al. · Gut · 2013 · 416 citations
Accurate measurement of cholecystokinin in plasma
Jens F. Rehfeld · Clinical Chemistry · 1998 · 319 citations
Caroline G. MacIntosh, Jane M. Andrews, Karen L. Jones et al. · American Journal of Clinical Nutrition · 1999 · 249 citations
Medicine, Endocrinology, Aging +12